Enanta Pharmaceuticals
ENTA
#7639
Rank
โ‚ฌ0.32 B
Marketcap
11,30ย โ‚ฌ
Share price
2.09%
Change (1 day)
130.13%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: โ‚ฌ0.32 Billion

As of January 2026 Enanta Pharmaceuticals has a market cap of โ‚ฌ0.32 Billion. This makes Enanta Pharmaceuticals the world's 7639th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ0.32 B-21.23%
2025โ‚ฌ0.41 B238.22%
2024โ‚ฌ0.12 B-31.72%
2023โ‚ฌ0.17 B-80.13%
2022โ‚ฌ0.90 B-33.38%
2021โ‚ฌ1.35 B97.01%
2020โ‚ฌ0.68 B-37.09%
2019โ‚ฌ1.09 B-9.21%
2018โ‚ฌ1.20 B28.64%
2017โ‚ฌ0.93 B54.25%
2016โ‚ฌ0.60 B6.84%
2015โ‚ฌ0.56 B-27.06%
2014โ‚ฌ0.77 B119.28%
2013โ‚ฌ0.35 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Enanta Pharmaceuticals was reported to be:

โ‚ฌ0.31 Billion
by Nasdaq info icon info icon
โ‚ฌ0.31 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AbbVie
ABBV
โ‚ฌ331.67 B 101,601.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ439.76 B 134,744.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ100.55 B 30,734.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ231.47 B 70,878.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ98.17 B 30,004.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ233.29 B 71,436.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland